Life Sciences and Healthcare Regulatory
Trusted FDA and healthcare regulatory lawyers counsel across the spectrum of complex FDA, healthcare and life sciences regulatory issues and defend against government enforcement actions
Why Cooley
-
Strategic FDA regulatory counsel across the product life cycle
Our US Food and Drug Administration (FDA) regulatory lawyers advise clients at every stage – from early-stage companies in clinical trials and those seeking FDA approval to established businesses with marketed products. We provide guidance on advertising and promotion, inspection readiness and representation before government agencies.
-
Comprehensive healthcare regulatory guidance
Our healthcare regulatory lawyers regularly counsel clients on reimbursement, coding and coverage; compliance with various federal and state healthcare laws, including those regulating the corporate practice of medicine; physician payment transparency laws; healthcare data privacy and protection; and licensure and accreditation.
-
Experienced representation in government litigation and investigations
Our FDA and healthcare lawyers represent clients in federal court litigation involving the government, as well as in government-facing investigations and enforcement actions. We bring deep experience and a strategic approach to resolving complex regulatory disputes.
-
Recognized leaders in FDA and healthcare law
We are consistently recognized for excellence in life sciences and healthcare by LMG Life Sciences and Chambers.
-
An integrated regulatory solution
We provide comprehensive and timely guidance through CooleyREG, our innovative approach that brings together regulatory practitioners from across the firm to help clients navigate every regulatory twist and turn.
The team has strong knowledge of the topics and nuances, great acumen and client relationships, providing a great service level and responsiveness.
Chambers USA, 2025
Cooley Releases Artificial Intelligence/Machine Learning Medical Device Regulatory Handbook
Our handbook is tailored for device software manufacturers navigating the complex regulatory issues surrounding patient access to innovative medical device technologies.